A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.

Clinical trial NCT07523100 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07523100
Sponsor: Daishi Tian
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)

Start date: 2026-04-07
Primary completion: 2027-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.